Feasibility Study of Interval Compressed Regimen Using Four-drugs for Osteosarcoma

NCT03390946 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

23

Enrollment

OTHER_GOV

Sponsor class

Conditions

Osteosarcoma
Feasibility
Treatment Response
Biomarker

Interventions

DRUG: Poor responder group adjuvant chemotherapy
DRUG: Good responder group adjuvant chemotherapy

Sponsor

Byung-Kiu Park

Collaborators

[object Object]
[object Object]